Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-16

Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Fexuprazan in Prevention of NSAIDs Induced Peptic Ulcer [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial is evaluating the efficacy and safety of fexuprazan to prevent NSAID-induced peptic ulcers; the study is currently not yet recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fexuprazan (fexuprazan)

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: NSAID (Non-Steroidal Anti-Inflammatory Drug) | Phase 4 | Status: NOT_YET_RECRUITING